Publication | Closed Access

Dual Antiplatelet Therapy and Heparin “Bridging” Significantly Increase the Risk of Bleeding Complications After Pacemaker or Implantable Cardioverter-Defibrillator Device Implantation

Percutaneous Coronary InterventionThrombosisDual Antiplatelet TherapyBleeding ComplicationsCardiovascular DiseaseBlood PlateletPlatelet AntagonistMedicineAnticoagulantCardiologyEmergency MedicineAnesthesiology